Antibody Drug Conjugate Against BCMA - 60% Response Rate in Refractory Myeloma

Antibody Drug Conjugate Against BCMA - 60% Response Rate in Refractory Myeloma

User Photo
moasc

2 years
85 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Amrita Krishnan, MD, from The Judy and Bernard Briskin Center For Multiple Myeloma Research talks about the antibody drug conjugate against BCMA - 60% response rate in refractory myeloma at MOASCs Spotlight On® Hematology in Huntington Beach.
Up Next Autoplay